Sponsored • AIRA Matrix at ECP 2025

AI-powered solutions for pathology

As digital transformation accelerates across healthcare, AIRA Matrix stands at the forefront of artificial intelligence innovation in pathology. The company will showcase its comprehensive portfolio of AI-driven diagnostic and analytical solutions at the upcoming European Congress of Pathology in Vienna this September.

Transforming pathology through artificial intelligence

AIRA Matrix has established itself as a leading provider of AI-powered solutions for healthcare and life sciences applications. The company's technology focuses on enhancing diagnostic accuracy, streamlining workflows, and extracting meaningful insights from digitally scanned pathological images. 

The company's approach centers on three core areas: 

  • reducing turnaround times while minimizing errors, 
  • combining multimodal data for predictive analysis and 
  • enabling predictive processes that go beyond traditional analytical methods. 

Service-based model democratizes access to AI technology

Recognizing that not all laboratories have the resources for large-scale AI implementation, AIRA Matrix is launching its Digital Pathology as a Service (DPaaS) in 2025. This innovative approach offers both pay-per-use and subscription models, making advanced AI analysis accessible to organizations of all sizes. 

The DPaaS will provide two distinct service tiers: Feature Quantification for straightforward analysis tasks involving limited image sets, and Subscription-Ready Solutions for complex analysis requirements with direct access to the company's Image Management System. 

ECP 2025 participation highlights European expansion

The company's participation in ECP 2025 reflects its growing presence in the European market, with established operations spanning multiple regions. Attendees will have the opportunity to experience live demonstrations of AIRA Matrix's AI solutions and discuss how these technologies can be integrated into their specific pathology workflows. 

For pathology professionals attending ECP 2025, AIRA Matrix represents an opportunity to explore how artificial intelligence can enhance diagnostic capabilities while maintaining the clinical expertise that remains central to pathological practice. 

Click here to learn more: AIRA Matrix website 

28.08.2025

Related articles

Photo

News • Integration of digital pathology and AI tools

Digital pathology partnership to streamline workflows and enhance diagnostics

Digital pathology software company Fujifilm Healthcare Europe and Ibex Medical Analytics, specializing in AI-powered cancer diagnostics, announce a formal partnership to support efficient and…

Photo

Article • Connected laboratory

Digitisation and automation: Game-changers in histopathology?

Often referred to as the ‘Achilles’ heel’ of histopathology, the sample entry has posed considerable challenges in pre-analytics for several decades. We visited the Munich-based lab automation…

Photo

News • Discovery of tumour indicating morphological changes

Prostate cancer: AI finds changes missed by pathologists

Men assessed as healthy may still have an early form of prostate cancer. Using AI, researchers found signs that were missed in more than 80% of samples of men who later developed cancer.

Related products

Subscribe to Newsletter